A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

July 31, 2028

Conditions

Solid Tumor

Interventions

DRUG

HRS-4508 tablet

Trial Locations (1)

RECRUITING

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT07003321 - A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter